Scleroderma 2011
DOI: 10.1007/978-1-4419-5774-0_12
|View full text |Cite
|
Sign up to set email alerts
|

Localized Forms of Scleroderma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 203 publications
1
2
0
Order By: Relevance
“…11 According to the literature data, there is no connection between antinuclear factor detection and any clinical form of JLS. 5 In our series sclerodermospecific antibodies and ds-DNA were detected in small percentage of ArIn patients and in none without it. It is no wonder, because these antibodies are mainly found in JSS.…”
Section: Resultssupporting
confidence: 48%
See 1 more Smart Citation
“…11 According to the literature data, there is no connection between antinuclear factor detection and any clinical form of JLS. 5 In our series sclerodermospecific antibodies and ds-DNA were detected in small percentage of ArIn patients and in none without it. It is no wonder, because these antibodies are mainly found in JSS.…”
Section: Resultssupporting
confidence: 48%
“…4 There are some data stating that antinuclear factor directly correlates with joint lesions. 5 Patients with rheumatic conditions often have mixed cryoglobulins, composed of class M and rheumatoid factor immunoglobulins, class G polyclonal immunoglobulins and fibronectin. The level of cryoglobulins also correlates with clinical and laboratory activity of scleroderma.…”
Section: Introductionmentioning
confidence: 99%
“…In the line of German classification, gLoS is diagnosed when at least three anatomical sites are affected . Furthermore, some authors acknowledge that gLoS is a term used to describe lesions covering more than 30% of the body surface …”
Section: Resultsmentioning
confidence: 99%